75 related articles for article (PubMed ID: 23387084)
1. [Molecular transport mechanism of pefloxacin mesylate binding with transferrin].
Guo M; Lu XW; Ran XY; Hu RH
Yao Xue Xue Bao; 2012 Nov; 47(11):1503-10. PubMed ID: 23387084
[TBL] [Abstract][Full Text] [Related]
2. Interaction of imatinib mesylate with human serum transferrin: The comparative spectroscopic studies.
Śliwińska-Hill U
Spectrochim Acta A Mol Biomol Spectrosc; 2017 Feb; 173():468-475. PubMed ID: 27718450
[TBL] [Abstract][Full Text] [Related]
3. Comparison of binding interactions of lomefloxacin to serum albumin and serum transferrin by resonance light scattering and fluorescence quenching methods.
Vahedian-Movahed H; Saberi MR; Chamani J
J Biomol Struct Dyn; 2011 Feb; 28(4):483-502. PubMed ID: 21142219
[TBL] [Abstract][Full Text] [Related]
4. Investigation on the interaction between tamoxifen and human holo-transferrin: determination of the binding mechanism by fluorescence quenching, resonance light scattering and circular dichroism methods.
Sarzehi S; Chamani J
Int J Biol Macromol; 2010 Nov; 47(4):558-69. PubMed ID: 20708639
[TBL] [Abstract][Full Text] [Related]
5. Studies on the binding of fulvic acid with transferrin by spectroscopic analysis.
Zhang XF; Yang G; Dong Y; Zhao YQ; Sun XR; Chen L; Chen HB
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Feb; 137():1280-5. PubMed ID: 25305622
[TBL] [Abstract][Full Text] [Related]
6. Binding interactions of pefloxacin mesylate with bovine lactoferrin and human serum albumin.
Fan JC; Chen X; Wang Y; Fan CP; Shang ZC
J Zhejiang Univ Sci B; 2006 Jun; 7(6):452-8. PubMed ID: 16691639
[TBL] [Abstract][Full Text] [Related]
7. Spectroscopic studies of the interaction mechanisms between mono-caffeoylquinic acids and transferrin.
Guan Y; Dong J; Chen S; Liu M; Wang D; Zhang X; Wang H; Lin Z
Spectrochim Acta A Mol Biomol Spectrosc; 2017 Jun; 181():82-90. PubMed ID: 28342427
[TBL] [Abstract][Full Text] [Related]
8. A mass spectrometric and molecular modelling study of cisplatin binding to transferrin.
Khalaila I; Allardyce CS; Verma CS; Dyson PJ
Chembiochem; 2005 Oct; 6(10):1788-95. PubMed ID: 16196027
[TBL] [Abstract][Full Text] [Related]
9. Investigation and comparison of the binding between tolvaptan and pepsin and trypsin: Multi-spectroscopic approaches and molecular docking.
Ma X; He J; Huang Y; Xiao Y; Wang Q; Li H
J Mol Recognit; 2017 May; 30(5):. PubMed ID: 27943449
[TBL] [Abstract][Full Text] [Related]
10. Constructing transferrin receptor targeted drug delivery system by using doxorubicin hydrochloride and vanadocene dichloride.
Zhang Y; Xiang J; Liu Y; Zhang X; Tang Y
Bioorg Med Chem Lett; 2011 Oct; 21(19):5982-6. PubMed ID: 21862329
[TBL] [Abstract][Full Text] [Related]
11. Structural change of N-glycan exposes hydrophobic surface of human transferrin.
Nagae M; Morita-Matsumoto K; Arai S; Wada I; Matsumoto Y; Saito K; Hashimoto Y; Yamaguchi Y
Glycobiology; 2014 Aug; 24(8):693-702. PubMed ID: 24780636
[TBL] [Abstract][Full Text] [Related]
12. Insights into the bacterial transferrin receptor: the structure of transferrin-binding protein B from Actinobacillus pleuropneumoniae.
Moraes TF; Yu RH; Strynadka NC; Schryvers AB
Mol Cell; 2009 Aug; 35(4):523-33. PubMed ID: 19716795
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of interaction between norfloxacin and trypsin studied by molecular spectroscopy and modeling.
Lu Y; Wang G; Lu X; Lv J; Xu M; Zhang W
Spectrochim Acta A Mol Biomol Spectrosc; 2010 Jan; 75(1):261-6. PubMed ID: 19910245
[TBL] [Abstract][Full Text] [Related]
14. Study of the interaction of deoxynivalenol with human serum albumin by spectroscopic technique and molecular modelling.
Li Y; Wang H; Jia B; Liu C; Liu K; Qi Y; Hu Z
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2013; 30(2):356-64. PubMed ID: 23205852
[TBL] [Abstract][Full Text] [Related]
15. Structural consequences of binding of UO2(2+) to apotransferrin: can this protein account for entry of uranium into human cells?
Vidaud C; Gourion-Arsiquaud S; Rollin-Genetet F; Torne-Celer C; Plantevin S; Pible O; Berthomieu C; Quéméneur E
Biochemistry; 2007 Feb; 46(8):2215-26. PubMed ID: 17266333
[TBL] [Abstract][Full Text] [Related]
16. Titanium preferential binding sites in human serum transferrin at physiological concentrations.
Nuevo-Ordoñez Y; Montes-Bayón M; Blanco González E; Sanz-Medel A
Metallomics; 2011 Dec; 3(12):1297-303. PubMed ID: 22041858
[TBL] [Abstract][Full Text] [Related]
17. Exploring the binding mechanism of dihydropyrimidinones to human serum albumin: spectroscopic and molecular modeling techniques.
Wang G; Wang D; Li X; Lu Y
Colloids Surf B Biointerfaces; 2011 May; 84(1):272-9. PubMed ID: 21306879
[TBL] [Abstract][Full Text] [Related]
18. Study on the interaction of a cyanine dye with human serum transferrin.
Zhang XF; Chen L; Yang QF; Li Q; Sun XR; Chen HB; Yang G; Tang YL
Luminescence; 2015 Dec; 30(8):1176-83. PubMed ID: 25736560
[TBL] [Abstract][Full Text] [Related]
19. Interactions of Chemically Synthesized Ferrihydrite Nanoparticles with Human Serum Transferrin: Insights from Fluorescence Spectroscopic Studies.
Chilom CG; Sandu N; Iftimie S; Bălăşoiu M; Rogachev A; Orelovich O; Stolyar S
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34210014
[TBL] [Abstract][Full Text] [Related]
20. Metal retention in human transferrin: consequences of solvent composition in analytical sample preparation methods.
Quarles CD; Randunu KM; Brumaghim JL; Marcus RK
Metallomics; 2011 Oct; 3(10):1027-34. PubMed ID: 21904748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
